# Sol-Gel Technologies Ltd. share price today (Sol-Gel Technologies Ltd., SLGL)

> Sol-Gel Technologies Ltd.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. SLGL · Healthcare · Biotechnology · data as of 4 November 2026. Page: https://www.sectoralpha.in/us/stocks/slgl

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $66.00 (+115.4% in a year)
- Revenue (Jun 2026): ₹0.0 B
- Profit (Jun 2026), incl. one-off: ₹0.0 B (one-off item, see below)
- Operating margin: −704.2% (−769.3 points on a year ago)

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. ## What is the Sol-Gel Technologies Ltd. share price today? Sol-Gel Technologies Ltd.'s share price was $66.00 at the close on 4 November 2026. That is 10.8% below its average price over the last 200 trading days. In the last 52 weeks it traded between $31 and $92, and at that close it sat 58% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 12 weeks running. Over the last 1 year the share price moved +711% while the S&P 500 moved +18%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 14 August 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Sol-Gel Technologies Ltd. pay? Sol-Gel Technologies Ltd. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Sol-Gel Technologies Ltd. on? Sol-Gel Technologies Ltd. is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Sol-Gel Technologies Ltd. profitable? Sol-Gel Technologies Ltd. posted a net loss of ₹0.004 B in the Jun 2026 quarter. That quarter includes a one-off gain bigger than its revenue, so the comparison with last year does not reflect normal business. The full FY25 year was a loss of ₹0.01 B. That loss is 622.8% of the quarter's revenue. The same quarter a year earlier earned ₹0.0 B. 8 of the last 10 reported quarters were loss-making. Jun 2026 profit was ₹0.0 B, −131.7% on a year earlier. Read this profit with care: at ₹0.0 B it is bigger than the quarter's whole revenue of ₹0.0 B. No business earns more than it takes in from sales, so this is a one-off item (for example a debt settlement, a tax write-back or an asset sale), not money the business earned. The underlying business is running at a −704.2% operating margin. The jump on last year, and any P/E built on this profit, come from the one-off, not from a real turn in earnings. This company reports in its home currency, not US dollars, so the money charts are left out here. The figures in the text are in that currency (₹); nothing is converted. ## How much revenue does Sol-Gel Technologies Ltd. make, and is it growing? Sol-Gel Technologies Ltd. reported ₹0.0 B of revenue in the Jun 2026 quarter, −96.6% on the same quarter a year earlier. Over 4 years it has grown −11.3% a year on average. The last full year, FY25, came in at ₹0.0 B. The last four reported quarters add to ₹0.0 B. The quarterly figures for FY23 do not add up to the full-year total on file, so those quarters are left out of the charts and sums. FY25 revenue was ₹0.0 B, +68.0% on the year before. Recent pace: the last four quarters grew −32.0% on average, against −11.3% a year over the longer run, so this year is growing slower than its own long-run rate. This company reports in its home currency, not US dollars, so the money charts are left out here. The figures in the text are in that currency (₹); nothing is converted. ## How much of its sales does Sol-Gel Technologies Ltd. keep? Sol-Gel Technologies Ltd.'s operating margin was −704.2% in the Jun 2026 quarter, 769.3 percentage points lower than the same quarter a year ago. Across 5 years it has been between −1,889.3% and 9.5%. The latest quarter is within that range. Why the margin moved: operating margin changed −769.3 percentage points on the year while gross margin changed −602.4 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is Sol-Gel Technologies Ltd.'s profit turning into cash? Sol-Gel Technologies Ltd.'s cash-flow history is too short to judge how much of its profit turns into cash. In FY25 it brought in ₹0.0 B of operating cash against ₹0.0 B of profit. After ₹0.0 B of spending on assets, ₹0.0 B was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. What to look at next: it spends almost nothing on new assets, so the cash goes on running the business. The next section shows the spending figures. This company reports in its home currency, not US dollars, so the money charts are left out here. The figures in the text are in that currency (₹); nothing is converted. ## Where does Sol-Gel Technologies Ltd.'s cash go? Sol-Gel Technologies Ltd. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent ₹0.0 B on assets over the last 3 years. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: ₹0.0 B over the last 3 years. In short: almost nothing is being spent on new assets, so the cash goes on running the business. This company reports in its home currency, not US dollars, so the money charts are left out here. The figures in the text are in that currency (₹); nothing is converted. ## What is Sol-Gel Technologies Ltd.'s P/E ratio, and how does it compare with its own history? Sol-Gel Technologies Ltd. has no P/E right now, because its earnings are negative. The revenue and margin sections are where a turn would show first. The P/E comes back here once profit turns positive. ## Is the Sol-Gel Technologies Ltd. business getting better or worse? Sol-Gel Technologies Ltd.'s business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 6 quarters of 1 measure, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. The latest quarter’s profit includes a one-off item bigger than the normal business, so the profit line is shown but does not count in this reading. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Sol-Gel Technologies Ltd. earn on its capital? Sol-Gel Technologies Ltd. earned a ROE of −27% in FY25. That is up from a low of −71% in FY23. Its return on capital used (ROIC) is left out: on sales this small it reads −27%, a number that says nothing useful about the business. It comes from a −31.6% net margin and 0.65× asset turnover (sales divided by assets). Why the return is what it is (FY25): a −31.6% net margin × 0.65× asset turnover × 1.31× leverage (assets divided by equity) ≈ −26.9% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. ## Does Sol-Gel Technologies Ltd. have too much debt? Sol-Gel Technologies Ltd. has total debt of ₹0.0 B against shareholder equity of ₹0.0 B as of Jun 2026, so its debt is 0.02× its equity, which is very little. Year by year, that ratio went from 0.03 in FY21 to 0.04 in FY25. So the returns on this page come from the business, not from borrowed money. This company reports in its home currency, not US dollars, so the money charts are left out here. The figures in the text are in that currency (₹); nothing is converted. ## What is the Sol-Gel Technologies Ltd. shareholding pattern? We have no ownership or short-position figures for Sol-Gel Technologies Ltd., so this section says so rather than fill the gap. At normal trading volumes, closing those positions would take about 3.2 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. ## How far is Sol-Gel Technologies Ltd. from balance-sheet trouble? For Sol-Gel Technologies Ltd., the Z-score is 9.46. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 9.46 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does Sol-Gel Technologies Ltd. rank in its industry? There is no score against its industry: Sol-Gel Technologies Ltd. is not among the largest members shown in this industry comparison for Biotechnology. The score ranks a company within its industry: each measure is scored against the other members. Without that group there is no score, so none is shown. ## Which companies is Sol-Gel Technologies Ltd. compared with? No sector comparison is shown here, not among the largest members shown in this industry comparison. ## Which companies are close to Sol-Gel Technologies Ltd. in size? Sol-Gel Technologies Ltd. is the 191st largest of 211 Biotechnology companies on Sector Alpha by market value (scores of 5 November 2026). Just above it: Evommune, Inc., InflaRx N.V. and Protalix BioTherapeutics, Inc. Just below it: Keros Therapeutics, Inc., Cartesian Therapeutics, Inc. and Artiva Biotherapeutics, Inc. ### Biotechnology companies close in size

1. [Evommune, Inc.](https://www.sectoralpha.in/us/stocks/evmn) $219 million
2. [InflaRx N.V.](https://www.sectoralpha.in/us/stocks/ifrx) $218 million
3. [Protalix BioTherapeutics, Inc.](https://www.sectoralpha.in/us/stocks/plx) $217 million
4. Sol-Gel Technologies Ltd. $216 million
5. [Keros Therapeutics, Inc.](https://www.sectoralpha.in/us/stocks/kros) $215 million
6. [Cartesian Therapeutics, Inc.](https://www.sectoralpha.in/us/stocks/rnac) $206 million
7. [Artiva Biotherapeutics, Inc.](https://www.sectoralpha.in/us/stocks/artv) $206 million

[All 211 Biotechnology companies, largest first](https://www.sectoralpha.in/us/sectors/biotechnology#all-companies)

### Companies close in size in other industries

1. [Richtech Robotics Inc.](https://www.sectoralpha.in/us/stocks/rr) $209 million · Specialty Industrial Machinery
2. [RideNow Group, Inc.](https://www.sectoralpha.in/us/stocks/rdnw) $209 million · Auto & Truck Dealerships
3. Sol-Gel Technologies Ltd. $209 million
4. [Expensify, Inc.](https://www.sectoralpha.in/us/stocks/exfy) $209 million · Software - Application
5. [Meridian Corporation](https://www.sectoralpha.in/us/stocks/mrbk) $208 million · Banks - Regional

## What else do people ask about Sol-Gel Technologies Ltd.? ### What were Sol-Gel Technologies Ltd. Ltd.'s latest quarterly results? Sol-Gel Technologies Ltd. reported revenue of ₹0.0 B and a net loss of ₹0.0 B for the Jun 2026 quarter. Revenue fell 96.6% and profit fell 131.7% compared with a year earlier. The operating margin was −704.2%, 769.3 percentage points lower than a year earlier (as of 4 November 2026). ### What is Sol-Gel Technologies Ltd. Ltd.'s market cap? Sol-Gel Technologies Ltd.'s market capitalisation is $216 M at a stock price of $66.00. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026). ### How is Sol-Gel Technologies Ltd. Ltd. performing? Sol-Gel Technologies Ltd.'s latest readings are below. In its latest quarter, revenue fell 96.6% and profit fell 131.7% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 12 weeks running. This describes what the data did, not a rating (as of 4 November 2026). ### Will Sol-Gel Technologies Ltd. Ltd.'s stock price go up? This page does not forecast Sol-Gel Technologies Ltd.'s stock price. What it shows instead: the stock price is $66.00. Nobody can reliably say which way a price will move, and this site does not try (as of 4 November 2026). ### Where is Sol-Gel Technologies Ltd. Ltd. in its business cycle? Sol-Gel Technologies Ltd.'s FY25 operating margin was −39.2%, against a 5-year range of −1,889.3% to 9.5%: the middle of its own range, neither a peak nor a low. The latest quarter was −704.2%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026). ### What could break the Sol-Gel Technologies Ltd. Ltd. story? Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026). ### Is Sol-Gel Technologies Ltd. Ltd. a stock worth studying right now? What the numbers show: Sol-Gel Technologies Ltd.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026). This is research, not advice. We’re not SEBI-registered.